Stevens M - Search Results

1

Stevens M, Oltean S. Stevens M, et al. J Am Soc Nephrol. 2016 Jun;27(6):1596-603. doi: 10.1681/ASN.2015080908. Epub 2016 Jan 13. J Am Soc Nephrol. 2016. PMID: 26763787 Free PMC article. Review.

2

Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy.

Oltean S, Qiu Y, Ferguson JK, Stevens M, Neal C, Russell A, Kaura A, Arkill KP, Harris K, Symonds C, Lacey K, Wijeyaratne L, Gammons M, Wylie E, Hulse RP, Alsop C, Cope G, Damodaran G, Betteridge KB, Ramnath R, Satchell SC, Foster RR, Ballmer-Hofer K, Donaldson LF, Barratt J, Baelde HJ, Harper SJ, Bates DO, Salmon AH. Oltean S, et al. Among authors: stevens m. J Am Soc Nephrol. 2015 Aug;26(8):1889-904. doi: 10.1681/ASN.2014040350. Epub 2014 Dec 26. J Am Soc Nephrol. 2015. PMID: 25542969 Free PMC article.

3

VEGF-A₁₆₅ b protects against proteinuria in a mouse model with progressive depletion of all endogenous VEGF-A splice isoforms from the kidney.

Stevens M, Neal CR, Salmon AHJ, Bates DO, Harper SJ, Oltean S. Stevens M, et al. J Physiol. 2017 Oct 1;595(19):6281-6298. doi: 10.1113/JP274481. Epub 2017 Jul 3. J Physiol. 2017. PMID: 28574576 Free PMC article.

4

Vascular Endothelial Growth Factor-A165b Restores Normal Glomerular Water Permeability in a Diphtheria-Toxin Mouse Model of Glomerular Injury.

Stevens M, Neal CR, Salmon AHJ, Bates DO, Harper SJ, Oltean S. Stevens M, et al. Nephron. 2018;139(1):51-62. doi: 10.1159/000485664. Epub 2018 Jan 26. Nephron. 2018. PMID: 29393270 Free PMC article.

5

Modulation of VEGF-A Alternative Splicing as a Novel Treatment in Chronic Kidney Disease.

Stevens M, Oltean S. Stevens M, et al. Genes (Basel). 2018 Feb 15;9(2):98. doi: 10.3390/genes9020098. Genes (Basel). 2018. PMID: 29462869 Free PMC article. Review.

6

Assessment of Kidney Function in Mouse Models of Glomerular Disease.

Stevens M, Oltean S. Stevens M, et al. J Vis Exp. 2018 Jun 30;(136):57764. doi: 10.3791/57764. J Vis Exp. 2018. PMID: 30010634 Free PMC article.

7

Anti-angiogenic isoform of vascular endothelial growth factor-A in cardiovascular and renal disease.

Kikuchi R, Stevens M, Harada K, Oltean S, Murohara T. Kikuchi R, et al. Among authors: stevens m. Adv Clin Chem. 2019;88:1-33. doi: 10.1016/bs.acc.2018.10.001. Epub 2018 Nov 16. Adv Clin Chem. 2019. PMID: 30612603 Review.

8

The natural drug DIAVIT is protective in a type II mouse model of diabetic nephropathy.

Stevens M, Neal CR, Craciun EC, Dronca M, Harper SJ, Oltean S. Stevens M, et al. PLoS One. 2019 Mar 13;14(3):e0212910. doi: 10.1371/journal.pone.0212910. eCollection 2019. PLoS One. 2019. PMID: 30865689 Free PMC article.

9

Modulation of Receptor Tyrosine Kinase Activity through Alternative Splicing of Ligands and Receptors in the VEGF-A/VEGFR Axis.

Stevens M, Oltean S. Stevens M, et al. Cells. 2019 Mar 28;8(4):288. doi: 10.3390/cells8040288. Cells. 2019. PMID: 30925751 Free PMC article. Review.

10

The VEGF-A exon 8 splicing-sensitive fluorescent reporter mouse is a novel tool to assess the effects of splicing regulatory compounds in vivo.

Stevens M, Star E, Lee M, Innes E, Li L, Bowler E, Harper S, Bates DO, Oltean S. Stevens M, et al. RNA Biol. 2019 Dec;16(12):1672-1681. doi: 10.1080/15476286.2019.1652522. Epub 2019 Aug 21. RNA Biol. 2019. PMID: 31432737 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,905 results

Search Page